Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection

Prim Care Companion CNS Disord. 2017 Nov 30;19(6):17l02125. doi: 10.4088/PCC.17l02125.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Humans
  • Injections
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Neuroleptic Malignant Syndrome / etiology
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*

Substances

  • Antipsychotic Agents
  • Risperidone